Literature DB >> 22262807

HIV-1 Nef mobilizes lipid rafts in macrophages through a pathway that competes with ABCA1-dependent cholesterol efflux.

Huanhuan L Cui1, Angela Grant, Nigora Mukhamedova, Tatiana Pushkarsky, Lucas Jennelle, Larisa Dubrovsky, Katharina Gaus, Michael L Fitzgerald, Dmitri Sviridov, Michael Bukrinsky.   

Abstract

HIV infection, through the actions of viral accessory protein Nef, impairs activity of cholesterol transporter ABCA1, inhibiting cholesterol efflux from macrophages and elevating the risk of atherosclerosis. Nef also induces lipid raft formation. In this study, we demonstrate that these activities are tightly linked and affect macrophage function and HIV replication. Nef stimulated lipid raft formation in macrophage cell line RAW 264.7, and lipid rafts were also mobilized in HIV-1-infected human monocyte-derived macrophages. Nef-mediated transfer of cholesterol to lipid rafts competed with the ABCA1-dependent pathway of cholesterol efflux, and pharmacological inhibition of ABCA1 functionality or suppression of ABCA1 expression by RNAi increased Nef-dependent delivery of cholesterol to lipid rafts. Nef reduced cell-surface accessibility of ABCA1 and induced ABCA1 catabolism via the lysosomal pathway. Despite increasing the abundance of lipid rafts, expression of Nef impaired phagocytic functions of macrophages. The infectivity of the virus produced in natural target cells of HIV-1 negatively correlated with the level of ABCA1. These findings demonstrate that Nef-dependent inhibition of ABCA1 is an essential component of the viral replication strategy and underscore the role of ABCA1 as an innate anti-HIV factor.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22262807      PMCID: PMC3307646          DOI: 10.1194/jlr.M023119

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  38 in total

1.  Regulated expression vectors demonstrate cell-type-specific sensitivity to human immunodeficiency virus type 1 Nef-induced cytostasis.

Authors:  S J Cooke; K Coates; C H Barton; T E Biggs; S J Barrett; A Cochrane; K Oliver; J A McKeating; M P Harris; D A Mann
Journal:  J Gen Virol       Date:  1997-02       Impact factor: 3.891

Review 2.  Human immunodeficiency virus infection and macrophage cholesterol metabolism.

Authors:  Michael Bukrinsky; Dmitri Sviridov
Journal:  J Leukoc Biol       Date:  2006-11       Impact factor: 4.962

3.  Mutation of the ATP cassette binding transporter A1 (ABCA1) C-terminus disrupts HIV-1 Nef binding but does not block the Nef enhancement of ABCA1 protein degradation.

Authors:  Zahedi Mujawar; Norimasa Tamehiro; Angela Grant; Dmitri Sviridov; Michael Bukrinsky; Michael L Fitzgerald
Journal:  Biochemistry       Date:  2010-09-28       Impact factor: 3.162

4.  Quantitative imaging of membrane lipid order in cells and organisms.

Authors:  Dylan M Owen; Carles Rentero; Astrid Magenau; Ahmed Abu-Siniyeh; Katharina Gaus
Journal:  Nat Protoc       Date:  2011-12-08       Impact factor: 13.491

Review 5.  ABC transporters, atherosclerosis and inflammation.

Authors:  Michael L Fitzgerald; Zahedi Mujawar; Norimasa Tamehiro
Journal:  Atherosclerosis       Date:  2010-01-21       Impact factor: 5.162

6.  Human immunodeficiency virus type 1 Nef recruits the guanine exchange factor Vav1 via an unexpected interface into plasma membrane microdomains for association with p21-activated kinase 2 activity.

Authors:  Susanne Rauch; Kati Pulkkinen; Kalle Saksela; Oliver T Fackler
Journal:  J Virol       Date:  2007-12-19       Impact factor: 5.103

7.  The role of different regions of ATP-binding cassette transporter A1 in cholesterol efflux.

Authors:  Nigora Mukhamedova; Ying Fu; Michael Bukrinsky; Alan T Remaley; Dmitri Sviridov
Journal:  Biochemistry       Date:  2007-07-26       Impact factor: 3.162

Review 8.  Role of HDL, ABCA1, and ABCG1 transporters in cholesterol efflux and immune responses.

Authors:  Laurent Yvan-Charvet; Nan Wang; Alan R Tall
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-10-01       Impact factor: 8.311

9.  HIV infection and high density lipoprotein metabolism.

Authors:  Honor Rose; Jennifer Hoy; Ian Woolley; Urbain Tchoua; Michael Bukrinsky; Anthony Dart; Dmitri Sviridov
Journal:  Atherosclerosis       Date:  2007-12-04       Impact factor: 5.162

10.  Caveolin-1-dependent and -independent membrane domains.

Authors:  Soazig Le Lay; Qiong Li; Nicholas Proschogo; Macarena Rodriguez; Krishanthi Gunaratnam; Siân Cartland; Carles Rentero; Wendy Jessup; Todd Mitchell; Katharina Gaus
Journal:  J Lipid Res       Date:  2008-12-12       Impact factor: 5.922

View more
  42 in total

1.  Analysis of ABCA1 and Cholesterol Efflux in HIV-Infected Cells.

Authors:  Nigora Mukhamedova; Beda Brichacek; Christina Darwish; Anastas Popratiloff; Dmitri Sviridov; Michael Bukrinsky
Journal:  Methods Mol Biol       Date:  2016

Review 2.  Risk of coronary heart disease in patients with HIV infection.

Authors:  Markella V Zanni; Judith Schouten; Steven K Grinspoon; Peter Reiss
Journal:  Nat Rev Cardiol       Date:  2014-10-21       Impact factor: 32.419

3.  Murine Norovirus Infection Variably Alters Atherosclerosis in Mice Lacking Apolipoprotein E.

Authors:  Charlie C Hsu; Jisun Paik; Thea L Brabb; Kevin D O'Brien; Jinkyu Kim; Brittany G Sullivan; Kelly L Hudkins; Audrey Seamons; Jennifer C Finley; Stacey M Meeker; Lillian Maggio-Price
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

Review 4.  Lipid biology of the podocyte--new perspectives offer new opportunities.

Authors:  Alessia Fornoni; Sandra Merscher; Jeffrey B Kopp
Journal:  Nat Rev Nephrol       Date:  2014-05-27       Impact factor: 28.314

Review 5.  Cdc42 - A tryst between host cholesterol metabolism and infection.

Authors:  Dmitri Sviridov; Nigora Mukhamedova
Journal:  Small GTPases       Date:  2016-08-31

6.  Cytomegalovirus Restructures Lipid Rafts via a US28/CDC42-Mediated Pathway, Enhancing Cholesterol Efflux from Host Cells.

Authors:  Hann Low; Nigora Mukhamedova; Huanhuan L Cui; Brian P McSharry; Selmir Avdic; Anh Hoang; Michael Ditiatkovski; Yingying Liu; Ying Fu; Peter J Meikle; Martin Blomberg; Konstantinos A Polyzos; William E Miller; Piotr Religa; Michael Bukrinsky; Cecilia Soderberg-Naucler; Barry Slobedman; Dmitri Sviridov
Journal:  Cell Rep       Date:  2016-06-16       Impact factor: 9.423

7.  Interaction Between HIV-1 Nef and Calnexin: From Modeling to Small Molecule Inhibitors Reversing HIV-Induced Lipid Accumulation.

Authors:  Ruth Hunegnaw; Marina Vassylyeva; Larisa Dubrovsky; Tatiana Pushkarsky; Dmitri Sviridov; Anastasia A Anashkina; Aykut Üren; Beda Brichacek; Dmitry G Vassylyev; Alexei A Adzhubei; Michael Bukrinsky
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-28       Impact factor: 8.311

Review 8.  Lipid rafts and pathogens: the art of deception and exploitation.

Authors:  Michael I Bukrinsky; Nigora Mukhamedova; Dmitri Sviridov
Journal:  J Lipid Res       Date:  2019-10-15       Impact factor: 5.922

9.  Small GTPase ARF6 Regulates Endocytic Pathway Leading to Degradation of ATP-Binding Cassette Transporter A1.

Authors:  Nigora Mukhamedova; Anh Hoang; Huanhuan L Cui; Irena Carmichael; Ying Fu; Michael Bukrinsky; Dmitri Sviridov
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-10-06       Impact factor: 8.311

Review 10.  The Intracellular Cholesterol Landscape: Dynamic Integrator of the Immune Response.

Authors:  Michael B Fessler
Journal:  Trends Immunol       Date:  2016-09-28       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.